Genetic Technologies Limited (GTG) is a diagnostics company specialising in genomics-based tests for health, wellness, and serious diseases through its geneType and EasyDNA brands. GTG provides cancer predictive testing and assessment tools designed to assist physicians in enhancing health outcomes for individuals worldwide. By leveraging advanced genetic insights, GTG aims to empower healthcare providers with the information needed to offer personalised care and proactive health management. Through its innovative approach, the company strives to make a significant impact on global health by improving early detection and prevention strategies for various conditions.